Pigmentary disorders


Depigmentation therapy refers to medical treatments that remove skin pigmentation. Depigmentation therapy is used in someone that has widespread, but incomplete, vitiligo on the face and/or other sites, in an attempt to improve their appearance. The most commonly used depigmenting agent is monobenzyl ether of hydroquinone (MBEH). If the patient cannot tolerate MBEH, or if treatment fails, combination therapies or other treatments may be considered. Depigmentation therapy may be considered in the management of treatment resistant vitiligo affecting more than 50% of the body surface area or affecting cosmetically sensitive, exposed body sites


    Related Conference of Pigmentary disorders

    July 28-29, 2025

    25th European Dermatology Congress

    Paris, France
    August 18-19, 2025

    15th International Conference on Cosmetology and Dermatology

    Dubai, UAE
    August 20-21, 2025

    26th World Dermatology Congress

    Paris, France
    August 21-22, 2025

    8th International Dermatology and Cosmetology Congress

    Dublin, Ireland
    August 26-27, 2025

    8th International Conference on Dermatology, Cosmetology and Plastic Surgery

    Paris, France
    September 15-16, 2025

    24th International Conference on Dermatology and Skin Care Sciences

    Paris, France
    September 24-25, 2025

    21st International Conference on Cosmetic Dermatology Trichology and Plastic Surgery

    London, UK
    November 17-18, 2025

    8th International Dermatology Conference: Skin and Body

    Paris, France
    December 08-09, 2025

    28th Global Summit on Dermatology, Skin Development and Ageing

    Toronto, Canada
    December 08-09, 2025

    30th International Conference on Dermatology & Skin Care

    Paris, France

    Pigmentary disorders Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in